ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global HAE Treatments Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-5H18377
Home | Market Reports | Health| Health Conditions| Skin Conditions
Global HAE Treatments Market Research Report 2024
BUY CHAPTERS

Global HAE Treatments Market Research Report 2024

Code: QYRE-Auto-5H18377
Report
October 2024
Pages:70
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Takeda Pharmaceuticals
BioCryst Pharmaceuticals
CSL Behring
Pharming Healthcare

HAE Treatments Market

HAE (Hereditary Angioedema) treatments aim to manage and prevent the unpredictable and potentially life-threatening swelling episodes associated with the condition. These treatments target the underlying cause: a deficiency or dysfunction of C1 esterase inhibitor (C1-INH), which leads to uncontrolled activation of the complement and kallikrein-kinin systems, resulting in swelling. There are three main categories of HAE treatments: C1-INH replacement therapies (e.g., Berinert, Haegarda) that restore functional C1-INH levels; kallikrein inhibitors (e.g., Ecallantide) that block the enzyme responsible for bradykinin production; and bradykinin B2 receptor antagonists (e.g., Icatibant) that prevent bradykinin from causing vascular permeability and swelling.
The global HAE Treatments market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for HAE Treatments is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for HAE Treatments is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of HAE Treatments include Takeda Pharmaceuticals, BioCryst Pharmaceuticals, CSL Behring, Pharming Healthcare, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for HAE Treatments, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HAE Treatments.
The HAE Treatments market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global HAE Treatments market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HAE Treatments manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of HAE Treatments Market Report

Report Metric Details
Report Name HAE Treatments Market
Segment by Type
  • C1 Esterase Inhibitors
  • Kallikrein Inhibitors
  • Bradykinin Receptor Antagonist
Segment by Application
  • Hospital and Clinic
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda Pharmaceuticals, BioCryst Pharmaceuticals, CSL Behring, Pharming Healthcare
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of HAE Treatments manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of HAE Treatments in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the HAE Treatments Market report?

Ans: The main players in the HAE Treatments Market are Takeda Pharmaceuticals, BioCryst Pharmaceuticals, CSL Behring, Pharming Healthcare

What are the Application segmentation covered in the HAE Treatments Market report?

Ans: The Applications covered in the HAE Treatments Market report are Hospital and Clinic, Pharmacy, Other

What are the Type segmentation covered in the HAE Treatments Market report?

Ans: The Types covered in the HAE Treatments Market report are C1 Esterase Inhibitors, Kallikrein Inhibitors, Bradykinin Receptor Antagonist

1 HAE Treatments Market Overview
1.1 Product Definition
1.2 HAE Treatments by Type
1.2.1 Global HAE Treatments Market Value Comparison by Type (2024-2030)
1.2.2 C1 Esterase Inhibitors
1.2.3 Kallikrein Inhibitors
1.2.4 Bradykinin Receptor Antagonist
1.3 HAE Treatments by Application
1.3.1 Global HAE Treatments Market Value by Application (2024-2030)
1.3.2 Hospital and Clinic
1.3.3 Pharmacy
1.3.4 Other
1.4 Global HAE Treatments Market Size Estimates and Forecasts
1.4.1 Global HAE Treatments Revenue 2019-2030
1.4.2 Global HAE Treatments Sales 2019-2030
1.4.3 Global HAE Treatments Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 HAE Treatments Market Competition by Manufacturers
2.1 Global HAE Treatments Sales Market Share by Manufacturers (2019-2024)
2.2 Global HAE Treatments Revenue Market Share by Manufacturers (2019-2024)
2.3 Global HAE Treatments Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of HAE Treatments, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of HAE Treatments, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of HAE Treatments, Product Type & Application
2.7 Global Key Manufacturers of HAE Treatments, Date of Enter into This Industry
2.8 Global HAE Treatments Market Competitive Situation and Trends
2.8.1 Global HAE Treatments Market Concentration Rate
2.8.2 The Global 5 and 10 Largest HAE Treatments Players Market Share by Revenue
2.8.3 Global HAE Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global HAE Treatments Market Scenario by Region
3.1 Global HAE Treatments Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global HAE Treatments Sales by Region: 2019-2030
3.2.1 Global HAE Treatments Sales by Region: 2019-2024
3.2.2 Global HAE Treatments Sales by Region: 2025-2030
3.3 Global HAE Treatments Revenue by Region: 2019-2030
3.3.1 Global HAE Treatments Revenue by Region: 2019-2024
3.3.2 Global HAE Treatments Revenue by Region: 2025-2030
3.4 North America HAE Treatments Market Facts & Figures by Country
3.4.1 North America HAE Treatments Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America HAE Treatments Sales by Country (2019-2030)
3.4.3 North America HAE Treatments Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe HAE Treatments Market Facts & Figures by Country
3.5.1 Europe HAE Treatments Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe HAE Treatments Sales by Country (2019-2030)
3.5.3 Europe HAE Treatments Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HAE Treatments Market Facts & Figures by Region
3.6.1 Asia Pacific HAE Treatments Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific HAE Treatments Sales by Region (2019-2030)
3.6.3 Asia Pacific HAE Treatments Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HAE Treatments Market Facts & Figures by Country
3.7.1 Latin America HAE Treatments Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America HAE Treatments Sales by Country (2019-2030)
3.7.3 Latin America HAE Treatments Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa HAE Treatments Market Facts & Figures by Country
3.8.1 Middle East and Africa HAE Treatments Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa HAE Treatments Sales by Country (2019-2030)
3.8.3 Middle East and Africa HAE Treatments Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HAE Treatments Sales by Type (2019-2030)
4.1.1 Global HAE Treatments Sales by Type (2019-2024)
4.1.2 Global HAE Treatments Sales by Type (2025-2030)
4.1.3 Global HAE Treatments Sales Market Share by Type (2019-2030)
4.2 Global HAE Treatments Revenue by Type (2019-2030)
4.2.1 Global HAE Treatments Revenue by Type (2019-2024)
4.2.2 Global HAE Treatments Revenue by Type (2025-2030)
4.2.3 Global HAE Treatments Revenue Market Share by Type (2019-2030)
4.3 Global HAE Treatments Price by Type (2019-2030)
5 Segment by Application
5.1 Global HAE Treatments Sales by Application (2019-2030)
5.1.1 Global HAE Treatments Sales by Application (2019-2024)
5.1.2 Global HAE Treatments Sales by Application (2025-2030)
5.1.3 Global HAE Treatments Sales Market Share by Application (2019-2030)
5.2 Global HAE Treatments Revenue by Application (2019-2030)
5.2.1 Global HAE Treatments Revenue by Application (2019-2024)
5.2.2 Global HAE Treatments Revenue by Application (2025-2030)
5.2.3 Global HAE Treatments Revenue Market Share by Application (2019-2030)
5.3 Global HAE Treatments Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Takeda Pharmaceuticals
6.1.1 Takeda Pharmaceuticals Company Information
6.1.2 Takeda Pharmaceuticals Description and Business Overview
6.1.3 Takeda Pharmaceuticals HAE Treatments Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Pharmaceuticals HAE Treatments Product Portfolio
6.1.5 Takeda Pharmaceuticals Recent Developments/Updates
6.2 BioCryst Pharmaceuticals
6.2.1 BioCryst Pharmaceuticals Company Information
6.2.2 BioCryst Pharmaceuticals Description and Business Overview
6.2.3 BioCryst Pharmaceuticals HAE Treatments Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BioCryst Pharmaceuticals HAE Treatments Product Portfolio
6.2.5 BioCryst Pharmaceuticals Recent Developments/Updates
6.3 CSL Behring
6.3.1 CSL Behring Company Information
6.3.2 CSL Behring Description and Business Overview
6.3.3 CSL Behring HAE Treatments Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSL Behring HAE Treatments Product Portfolio
6.3.5 CSL Behring Recent Developments/Updates
6.4 Pharming Healthcare
6.4.1 Pharming Healthcare Company Information
6.4.2 Pharming Healthcare Description and Business Overview
6.4.3 Pharming Healthcare HAE Treatments Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pharming Healthcare HAE Treatments Product Portfolio
6.4.5 Pharming Healthcare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HAE Treatments Industry Chain Analysis
7.2 HAE Treatments Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HAE Treatments Production Mode & Process
7.4 HAE Treatments Sales and Marketing
7.4.1 HAE Treatments Sales Channels
7.4.2 HAE Treatments Distributors
7.5 HAE Treatments Customers
8 HAE Treatments Market Dynamics
8.1 HAE Treatments Industry Trends
8.2 HAE Treatments Market Drivers
8.3 HAE Treatments Market Challenges
8.4 HAE Treatments Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Takeda Pharmaceuticals
BioCryst Pharmaceuticals
CSL Behring
Pharming Healthcare
List of Tables
 Table 1. Global HAE Treatments Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global HAE Treatments Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global HAE Treatments Market Competitive Situation by Manufacturers in 2023
 Table 4. Global HAE Treatments Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global HAE Treatments Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global HAE Treatments Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global HAE Treatments Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market HAE Treatments Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of HAE Treatments, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of HAE Treatments, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of HAE Treatments, Product Type & Application
 Table 12. Global Key Manufacturers of HAE Treatments, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global HAE Treatments by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HAE Treatments as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global HAE Treatments Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global HAE Treatments Sales by Region (2019-2024) & (K Units)
 Table 18. Global HAE Treatments Sales Market Share by Region (2019-2024)
 Table 19. Global HAE Treatments Sales by Region (2025-2030) & (K Units)
 Table 20. Global HAE Treatments Sales Market Share by Region (2025-2030)
 Table 21. Global HAE Treatments Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global HAE Treatments Revenue Market Share by Region (2019-2024)
 Table 23. Global HAE Treatments Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global HAE Treatments Revenue Market Share by Region (2025-2030)
 Table 25. North America HAE Treatments Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America HAE Treatments Sales by Country (2019-2024) & (K Units)
 Table 27. North America HAE Treatments Sales by Country (2025-2030) & (K Units)
 Table 28. North America HAE Treatments Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America HAE Treatments Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe HAE Treatments Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe HAE Treatments Sales by Country (2019-2024) & (K Units)
 Table 32. Europe HAE Treatments Sales by Country (2025-2030) & (K Units)
 Table 33. Europe HAE Treatments Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe HAE Treatments Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific HAE Treatments Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific HAE Treatments Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific HAE Treatments Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific HAE Treatments Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific HAE Treatments Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America HAE Treatments Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America HAE Treatments Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America HAE Treatments Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America HAE Treatments Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America HAE Treatments Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa HAE Treatments Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa HAE Treatments Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa HAE Treatments Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa HAE Treatments Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa HAE Treatments Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global HAE Treatments Sales (K Units) by Type (2019-2024)
 Table 51. Global HAE Treatments Sales (K Units) by Type (2025-2030)
 Table 52. Global HAE Treatments Sales Market Share by Type (2019-2024)
 Table 53. Global HAE Treatments Sales Market Share by Type (2025-2030)
 Table 54. Global HAE Treatments Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global HAE Treatments Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global HAE Treatments Revenue Market Share by Type (2019-2024)
 Table 57. Global HAE Treatments Revenue Market Share by Type (2025-2030)
 Table 58. Global HAE Treatments Price (US$/Unit) by Type (2019-2024)
 Table 59. Global HAE Treatments Price (US$/Unit) by Type (2025-2030)
 Table 60. Global HAE Treatments Sales (K Units) by Application (2019-2024)
 Table 61. Global HAE Treatments Sales (K Units) by Application (2025-2030)
 Table 62. Global HAE Treatments Sales Market Share by Application (2019-2024)
 Table 63. Global HAE Treatments Sales Market Share by Application (2025-2030)
 Table 64. Global HAE Treatments Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global HAE Treatments Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global HAE Treatments Revenue Market Share by Application (2019-2024)
 Table 67. Global HAE Treatments Revenue Market Share by Application (2025-2030)
 Table 68. Global HAE Treatments Price (US$/Unit) by Application (2019-2024)
 Table 69. Global HAE Treatments Price (US$/Unit) by Application (2025-2030)
 Table 70. Takeda Pharmaceuticals Company Information
 Table 71. Takeda Pharmaceuticals Description and Business Overview
 Table 72. Takeda Pharmaceuticals HAE Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Takeda Pharmaceuticals HAE Treatments Product
 Table 74. Takeda Pharmaceuticals Recent Developments/Updates
 Table 75. BioCryst Pharmaceuticals Company Information
 Table 76. BioCryst Pharmaceuticals Description and Business Overview
 Table 77. BioCryst Pharmaceuticals HAE Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. BioCryst Pharmaceuticals HAE Treatments Product
 Table 79. BioCryst Pharmaceuticals Recent Developments/Updates
 Table 80. CSL Behring Company Information
 Table 81. CSL Behring Description and Business Overview
 Table 82. CSL Behring HAE Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. CSL Behring HAE Treatments Product
 Table 84. CSL Behring Recent Developments/Updates
 Table 85. Pharming Healthcare Company Information
 Table 86. Pharming Healthcare Description and Business Overview
 Table 87. Pharming Healthcare HAE Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Pharming Healthcare HAE Treatments Product
 Table 89. Pharming Healthcare Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. HAE Treatments Distributors List
 Table 93. HAE Treatments Customers List
 Table 94. HAE Treatments Market Trends
 Table 95. HAE Treatments Market Drivers
 Table 96. HAE Treatments Market Challenges
 Table 97. HAE Treatments Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of HAE Treatments
 Figure 2. Global HAE Treatments Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global HAE Treatments Market Share by Type: 2023 & 2030
 Figure 4. C1 Esterase Inhibitors Product Picture
 Figure 5. Kallikrein Inhibitors Product Picture
 Figure 6. Bradykinin Receptor Antagonist Product Picture
 Figure 7. Global HAE Treatments Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global HAE Treatments Market Share by Application: 2023 & 2030
 Figure 9. Hospital and Clinic
 Figure 10. Pharmacy
 Figure 11. Other
 Figure 12. Global HAE Treatments Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global HAE Treatments Market Size (2019-2030) & (US$ Million)
 Figure 14. Global HAE Treatments Sales (2019-2030) & (K Units)
 Figure 15. Global HAE Treatments Average Price (US$/Unit) & (2019-2030)
 Figure 16. HAE Treatments Report Years Considered
 Figure 17. HAE Treatments Sales Share by Manufacturers in 2023
 Figure 18. Global HAE Treatments Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest HAE Treatments Players: Market Share by Revenue in HAE Treatments in 2023
 Figure 20. HAE Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global HAE Treatments Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America HAE Treatments Sales Market Share by Country (2019-2030)
 Figure 23. North America HAE Treatments Revenue Market Share by Country (2019-2030)
 Figure 24. United States HAE Treatments Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada HAE Treatments Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe HAE Treatments Sales Market Share by Country (2019-2030)
 Figure 27. Europe HAE Treatments Revenue Market Share by Country (2019-2030)
 Figure 28. Germany HAE Treatments Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France HAE Treatments Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. HAE Treatments Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy HAE Treatments Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia HAE Treatments Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific HAE Treatments Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific HAE Treatments Revenue Market Share by Region (2019-2030)
 Figure 35. China HAE Treatments Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan HAE Treatments Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea HAE Treatments Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India HAE Treatments Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia HAE Treatments Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan HAE Treatments Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia HAE Treatments Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America HAE Treatments Sales Market Share by Country (2019-2030)
 Figure 43. Mexico HAE Treatments Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil HAE Treatments Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina HAE Treatments Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia HAE Treatments Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa HAE Treatments Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa HAE Treatments Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey HAE Treatments Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia HAE Treatments Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE HAE Treatments Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of HAE Treatments by Type (2019-2030)
 Figure 53. Global Revenue Market Share of HAE Treatments by Type (2019-2030)
 Figure 54. Global HAE Treatments Price (US$/Unit) by Type (2019-2030)
 Figure 55. Global Sales Market Share of HAE Treatments by Application (2019-2030)
 Figure 56. Global Revenue Market Share of HAE Treatments by Application (2019-2030)
 Figure 57. Global HAE Treatments Price (US$/Unit) by Application (2019-2030)
 Figure 58. HAE Treatments Value Chain
 Figure 59. HAE Treatments Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global HAE Treatments Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-5H18377
Wed Oct 16 00:00:00 UTC 2024

Add to Cart

Dermatology Telehealth - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-30Q13927
Tue Oct 15 00:00:00 UTC 2024

Add to Cart

Chronic Granulomatous Disease (CGD) Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-34O12931
Mon Oct 14 00:00:00 UTC 2024

Add to Cart

Drugs for Blau Syndrome - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-16L13206
Fri Oct 11 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions